Cytogam
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
49591-532 -
Package NDC
49591-532-51 -
Application number
BLA103189 -
SPL ID
59d63ee0-9e77-824d-e063-6394a90ae055 -
SPL set ID
c8e2bb3f-2a4d-4c55-b145-ba96c1928d44 -
UNII
129L90A25N -
RxCUI
204528 -
RxCUI
209029
What the source publishes
- Labeler
- Kamada Ltd.
- Active ingredients
- HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN
- Form
- LIQUID
- Routes
- INTRAVENOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- PLASMA DERIVATIVE
Names this record is found by
Complete source data
{
"name": "Cytogam",
"splId": "59d63ee0-9e77-824d-e063-6394a90ae055",
"labels": [
{
"setId": "c8e2bb3f-2a4d-4c55-b145-ba96c1928d44",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c8e2bb3f-2a4d-4c55-b145-ba96c1928d44",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c8e2bb3f-2a4d-4c55-b145-ba96c1928d44"
}
],
"routes": [
"INTRAVENOUS"
],
"labeler": "Kamada Ltd.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 VIAL, GLASS in 1 CARTON (49591-532-51) / 50 mL in 1 VIAL, GLASS (49591-532-50)",
"package_ndc": "49591-532-51",
"identifierStatus": "well-formed",
"marketing_start_date": "20230601"
}
],
"productId": "49591-532_59d63ee0-9e77-824d-e063-6394a90ae055",
"useDomain": "unknown",
"dosageForm": "LIQUID",
"productNdc": "49591-532",
"deaSchedule": null,
"genericName": "HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN",
"productType": "PLASMA DERIVATIVE",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN",
"strength": "2500 mg/50mL"
}
],
"applicationNumber": "BLA103189",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20230601",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "unknown",
"harmonizedIdentifiers": {
"nui": [
"N0000184165",
"N0000183365",
"N0000184009",
"N0000184152",
"M0011122"
],
"unii": [
"129L90A25N"
],
"rxcui": [
"204528",
"209029"
],
"spl_set_id": [
"c8e2bb3f-2a4d-4c55-b145-ba96c1928d44"
],
"pharm_class_cs": [
"Immunoglobulins [CS]"
],
"pharm_class_pe": [
"Passively Acquired Immunity [PE]"
],
"pharm_class_epc": [
"Human Immunoglobulin G [EPC]"
],
"pharm_class_moa": [
"Virus Neutralization [MoA]"
],
"manufacturer_name": [
"Kamada Ltd."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:49591-532_59d63ee0-9e77-824d-e063-6394a90ae055"